Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01455
|
|||||
| Drug Name |
Hydroxybupropion
|
|||||
| Synonyms |
Hydroxybupropion
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Major depressive disorder [ICD11: 6A70.3] | Discontinued in Phase 2 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C13H18ClNO2
|
|||||
| Canonical SMILES |
CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)CO
|
|||||
| InChI |
InChI=1S/C13H18ClNO2/c1-9(15-13(2,3)8-16)12(17)10-5-4-6-11(14)7-10/h4-7,9,15-16H,8H2,1-3H3
|
|||||
| InChIKey |
AKOAEVOSDHIVFX-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 92264-81-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 255.74 | Topological Polar Surface Area | 49.3 | ||
| Heavy Atom Count | 17 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
2.2
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Emerging drugs for bipolar disorder. Expert Opin Emerg Drugs. 2006 Nov;11(4):621-34. | |||||
| 2 | Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein. Biol Pharm Bull. 2008 Feb;31(2):231-4. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.